ORIC Pharmaceuticals, Inc. (ORIC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -32.44M | -22.48M | -25.11M | -30.84M | -32.77M | -28.05M | -28.8M | -25.63M | -30.35M | -24.27M | -19.64M | -21.14M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 1.03% | 19.86% | 12.8% | -20.36% | -7.98% | -15.59% | -46.59% | -21.19% | -47.15% | -58.33% | -1.68% | -18.95% |
| Net Income | -35.77M | -30.5M | -32.59M | -36.35M | -30.02M | -36.31M | -34.57M | -31.96M | -25.01M | -28.33M | -25.48M | -22.94M |
| Depreciation & Amortization | 270K | 320K | 288K | 310K | 302K | 304K | 270K | 272K | 261K | 263K | 257K | 259K |
| Stock-Based Compensation | 6.9M | 6.28M | 5.63M | 6.57M | 0 | 5.2M | 5.06M | 5M | 4.96M | 3.92M | 3.86M | 3.83M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 162K | -240K | -587K | -591K | 5.43M | -1.63M | -1.95M | -2.3M | -2.4M | -2.11M | -1.92M | -1.25M |
| Working Capital Changes | -4M | 1.66M | 2.14M | -780K | -8.49M | 4.38M | 2.39M | 3.37M | -8.17M | 1.98M | 3.63M | -1.03M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -448K | 0 | 0 | -7.91M | 3.03M | 757K | 3.8M | -5.76M | 0 | 3.91M | 0 |
| Cash from Investing | -17.98M | 16.98M | -110.53M | -76.93M | 22.45M | 42.66M | 23.07M | 18.28M | -61.87M | 20.96M | -57.83M | -19.31M |
| Capital Expenditures | -2K | -450K | -35K | -63K | -387K | -219K | 551K | -333K | -218K | -57K | -77K | -405K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 223K | 0 | 0 | 0 | 0 | -969K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 61.14M | 1.5M | 109.45M | 134.3M | 253K | 575K | 126K | 816K | 125.2M | 453K | 31K | 85.17M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 62.13M | 1.5M | 110.44M | 133.93M | 253K | 575K | 126K | 816K | 125M | 226K | 31K | 85M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -993K | 0 | -993K | 377K | 0 | 0 | 0 | 0 | 198K | 227K | 0 | 174K |
| Net Change in Cash | 10.73M | -4M | -26.2M | 26.53M | -10.07M | 15.18M | -5.6M | -6.53M | 32.98M | -2.85M | -77.44M | 44.72M |
| Free Cash Flow | -32.44M | -22.87M | -25.15M | -30.91M | -33.16M | -28.27M | -29.21M | -25.96M | -30.57M | -24.33M | -19.72M | -21.55M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 2.18% | 19.11% | 13.92% | -19.06% | -8.47% | -16.22% | -48.13% | -20.45% | -46.01% | -55.78% | -0.01% | -16.85% |
| FCF per Share | -0.31 | -0.26 | -0.25 | -0.40 | -0.47 | -0.40 | -0.41 | -0.37 | -0.45 | -0.42 | -0.34 | -0.47 |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.74x | 0.77x | 0.85x | 1.09x | 0.77x | 0.83x | 0.80x | 1.21x | 0.86x | 0.77x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |